Alcimed Inc

An overview of opportunities and threats of therapeutic vaccines

As reliable information is getting more accessible, how will medical representation evolve? Alcimed, an Innovation and New Business consulting firm shares it view.

Type-1 diabetes incidence worldwide is increasing at 2-5% yearly, and approximately 300,000 patients use insulin pumps to control their disease. Current pump technology requires constant manual input of information. Researchers aspire to eliminate

Alcimed, an Innovation and New Business consulting firm, addresses the case of medical foods indications, their trends and new opportunities on this market for industry players

Having worked with a great number of companies developing orphan drugs over the past 20 years, Alcimed – an Innovation and New Business consulting firm – gives an overview of the orphan drug market and addresses the sustainability of its model in the...